{"url_path":"/sec/nvct/8-k/2026-06-30/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1875558/0001104659-26-079360-index.html","accession_number":"0001104659-26-079360","cik":"0001875558","ticker":"NVCT","issuer_name":"Nuvectis Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1875558/0001104659-26-079360-index.html","primary_entity_key":"0001875558","primary_entity_name":"Nuvectis Pharma, Inc."},"word_count":64,"has_tables":true,"body_markdown":"**Item 8.01. Other Events.**\n\n \n\nOn June 29, 2026, the\nCompany issued a press release to announce the launch of the Offering. On June 29, 2026, the Company issued a press release to announce\nthe pricing of the Offering. Copies of the press releases are filed as Exhibits 99.1 and 99.2, respectively, to this Current Report on\nForm 8-K and are incorporated herein by reference."}